CSF-1R-ANTIKÖRPERFORMULIERUNG
European patent · EP3849518 · In force
Register entry
- Publication number
- EP3849518
- Application number
- EP19765736
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 12, 2019
- Published
- Jul 21, 2021
- Granted
- Mar 18, 2026
- Protection ends at the latest
- Sep 11, 2039
- Next annual fee due
- Sep 30, 2027
- IPC classes
- A61K 9/08 (2006.01)A61K 9/19 (2006.01)A61K 39/395 (2006.01)A61P 35/00 (2006.01)A61P 19/02 (2006.01)C07K 16/28 (2006.01)A61K 45/06 (2006.01)A61K 47/26 (2006.01)
- Priority
- EP 18194145 13.09.2018
- PCT application
- PCT/EP2019/074303 12.09.2019
- PCT publication
- WO2020/053321 19.03.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Jun 24, 2026
Owner
- Owner
- F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel → F. Hoffmann-La Roche AG, Grenzacherstraße 124, 4070 Basel
Published in Swissreg on 24.06.2026
- Mar 18, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 18.03.2026
Parties
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.